<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39391697</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Potential of traditional medicines in alleviating COVID-19 symptoms.</ArticleTitle><Pagination><StartPage>1452616</StartPage><MedlinePgn>1452616</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1452616</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2024.1452616</ELocationID><Abstract><AbstractText>This review discusses the prevention and treatment of coronavirus disease 2019 (COVID-19) caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Mutations in its spike glycoprotein have driven the emergence of variants with high transmissibility and immune escape capabilities. Some antiviral drugs are ineffective against the BA.2 subvariant at the authorized dose. Recently, 150 natural metabolites have been identified as potential candidates for development of new anti-COVID-19 drugs with higher efficacy and lower toxicity than those of existing therapeutic agents. Botanical drug-derived bioactive molecules have shown promise in dampening the COVID-19 cytokine storm and thus preventing pulmonary fibrosis, as they exert a strong binding affinity for viral proteins and inhibit their activity. The Health Ministry of Thailand has approved <i>Andrographis paniculata</i> (Jap. Senshinren) extracts to treat COVID-19. In China, over 85% of patients infected with SARS-CoV-2 receive treatments based on traditional Chinese medicine. A comprehensive map of the stages and pathogenetic mechanisms related to the disease and effective natural products to treat and prevent COVID-19 are presented. Approximately 10% of patients with COVID-19 are affected by long COVID, and COVID-19 infection impairs mitochondrial DNA. As the number of agents to treat COVID-19 is limited, adjuvant botanical drug treatments including vitamin C and E supplementation may reduce COVID-19 symptoms and inhibit progression to long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Chatatikun, Indo, Imai, Kawakami, Kubo, Kitagawa, Ichikawa, Udomwech, Phongphithakchai, Sarakul, Sukati, Somsak, Ichikawa, Klangbud, Nissapatorn, Tangpong and Majima.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chatatikun</LastName><ForeName>Moragot</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence Research for Melioidosis and Microorganisms, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Indo</LastName><ForeName>Hiroko P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amanogawa Galaxy Astronomy Research Center, Kagoshima University Graduate School of Engineering, Kagoshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imai</LastName><ForeName>Motoki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Administration, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawakami</LastName><ForeName>Fumitaka</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Administration, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Microbiology, Kitasato University School of Allied Health Sciences, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Microbiology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitagawa</LastName><ForeName>Yoshimasa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Oral Diagnosis and Medicine, Division of Oral Pathobiological Science, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichikawa</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udomwech</LastName><ForeName>Lunla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phongphithakchai</LastName><ForeName>Atthaphong</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarakul</LastName><ForeName>Orawan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sukati</LastName><ForeName>Suriyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somsak</LastName><ForeName>Voravuth</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichikawa</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Administration, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klangbud</LastName><ForeName>Wiyada Kwanhian</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Medical Technology Program, Faculty of Science, Nakhon Phanom University, Nakhon Phanom, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nissapatorn</LastName><ForeName>Veeranoot</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangpong</LastName><ForeName>Jitbanjong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majima</LastName><ForeName>Hideyuki J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">botanical drugs</Keyword><Keyword MajorTopicYN="N">immune evasion</Keyword><Keyword MajorTopicYN="N">immune reaction</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">natural metabolites</Keyword><Keyword MajorTopicYN="N">oxidative disease</Keyword><Keyword MajorTopicYN="N">traditional medicine</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39391697</ArticleId><ArticleId IdType="pmc">PMC11464457</ArticleId><ArticleId IdType="doi">10.3389/fphar.2024.1452616</ArticleId><ArticleId IdType="pii">1452616</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ali S., Alam M., Khatoon F., Fatima U., Elasbali A. M., Adnan M., et al. (2022). Natural products can be used in therapeutic management of COVID-19: probable mechanistic insights. Biomed. Pharmacother. 147, 112658. 10.1016/j.biopha.2022.112658</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.112658</ArticleId><ArticleId IdType="pmc">PMC8769927</ArticleId><ArticleId IdType="pubmed">35066300</ArticleId></ArticleIdList></Reference><Reference><Citation>
Anderson L. A. (2023). Available at: https://www.drugs.com/medical-answers/paxlovid-side-effects-8-key-things-3573430/ (Accessed June 20, 2024).</Citation></Reference><Reference><Citation>Ang L., Lee H. W., Kim A., Lee M. S. (2020). Herbal medicine for the management of COVID-19 during the medical observation period: a review of guidelines. Integr. Med. Res. 9, 100465. 10.1016/j.imr.2020.100465</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imr.2020.100465</ArticleId><ArticleId IdType="pmc">PMC7328533</ArticleId><ArticleId IdType="pubmed">32691000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang L., Song E., Hu X. Y., Lee H. W., Chen Y., Lee M. S. (2022). Herbal medicine intervention for the treatment of COVID-19: a living systematic review and cumulative meta-analysis. Front. Pharmacol. 13, 906764. 10.3389/fphar.2022.906764</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.906764</ArticleId><ArticleId IdType="pmc">PMC9251500</ArticleId><ArticleId IdType="pubmed">35795550</ArticleId></ArticleIdList></Reference><Reference><Citation>Arribas J. R., Bhagani S., Lobo S. M., Khaertynova I., Mateu L., Fishchuk R., et al. (2022). Randomized trial of Molnupiravir or placebo in patients hospitalized with Covid-19. NEJM Evid. 1, EVIDoa2100044. 10.1056/EVIDoa2100044</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/EVIDoa2100044</ArticleId><ArticleId IdType="pubmed">38319178</ArticleId></ArticleIdList></Reference><Reference><Citation>Aungst C., Murdock J. (2023). Paxlovid vs. Molnupiravir (Lagevrio): how do they compare for COVID-19?</Citation></Reference><Reference><Citation>Beltr&#xe1;n-Garc&#xed;a J., Osca-Verdegal R., Pallard&#xf3; F. V., Ferreres J., Rodr&#xed;guez M., Mulet S., et al. (2020). Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants (Basel) 9, 936. 10.3390/antiox9100936</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9100936</ArticleId><ArticleId IdType="pmc">PMC7599810</ArticleId><ArticleId IdType="pubmed">33003552</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki T. K. (2021). Lifting of COVID-19 restrictions in the UK and the Delta variant. Lancet Respir. Med. 9, e85. 10.1016/s2213-2600(21)00328-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(21)00328-3</ArticleId><ArticleId IdType="pmc">PMC8275031</ArticleId><ArticleId IdType="pubmed">34265238</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A., Troiani E., Corrao S. (2020). COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. a narrative review. Clin. Pract. 10, 1271. 10.4081/cp.2020.1271</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarti R., Singh R., Ghosh A., Dey D., Sharma P., Velayutham R., et al. (2021). A review on potential of natural products in the management of COVID-19. RSC Adv. 11, 16711&#x2013;16735. 10.1039/D1RA00644D</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1RA00644D</ArticleId><ArticleId IdType="pmc">PMC9031656</ArticleId><ArticleId IdType="pubmed">35479175</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G., Pizzocaro A., Vena W., Rastrelli G., Semeraro F., Isidori A. M., et al. (2021). Diabetes is most important cause for mortality in COVID-19 hospitalized patients: systematic review and meta-analysis. Rev. Endocr. Metab. Disord. 22, 275&#x2013;296. 10.1007/s11154-021-09630-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09630-8</ArticleId><ArticleId IdType="pmc">PMC7899074</ArticleId><ArticleId IdType="pubmed">33616801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cubuk J., Alston J. J., Incicco J. J., Singh S., Stuchell-Brereton M. D., Ward M. D., et al. (2021). The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA. Nat. Commun. 12, 1936. 10.1038/s41467-021-21953-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21953-3</ArticleId><ArticleId IdType="pmc">PMC8007728</ArticleId><ArticleId IdType="pubmed">33782395</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silveira M. P., Da Silva Fagundes K. K., Bizuti M. R., Starck &#xc9;., Rossi R. C., De Resende E. S. D. T. (2021). Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature. Clin. Exp. Med. 21, 15&#x2013;28. 10.1007/s10238-020-00650-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00650-3</ArticleId><ArticleId IdType="pmc">PMC7387807</ArticleId><ArticleId IdType="pubmed">32728975</ArticleId></ArticleIdList></Reference><Reference><Citation>Demeke C. A., Woldeyohanins A. E., Kifle Z. D. (2021). Herbal medicine use for the management of COVID-19: a review article. Metab. Open 12, 100141. 10.1016/j.metop.2021.100141</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2021.100141</ArticleId><ArticleId IdType="pmc">PMC8519661</ArticleId><ArticleId IdType="pubmed">34693242</ArticleId></ArticleIdList></Reference><Reference><Citation>
Drugs.Com (2023). Available at: https://www.drugs.com/ (Accessed September, 2024).</Citation></Reference><Reference><Citation>Edeas M., Saleh J., Peyssonnaux C. (2020). Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis? Int. J. Infect. Dis. 97, 303&#x2013;305. 10.1016/j.ijid.2020.05.110</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.110</ArticleId><ArticleId IdType="pmc">PMC7264936</ArticleId><ArticleId IdType="pubmed">32497811</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili-Nadimi A., Imanparast F., Alizadeh S., Vatannejad A., Mohaghegh P., Seyedmehdi S. M., et al. (2023). Total antioxidant capacity and total oxidant status and disease severity in a cohort study of COVID-19 patients. Clin. Lab. 69. 10.7754/Clin.Lab.2022.220416</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2022.220416</ArticleId><ArticleId IdType="pubmed">36787558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y., Wang Y., Yu S., Chang J., Yan Y., Wang Y., et al. (2021). Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review. Chin. Med. 16, 67. 10.1186/s13020-021-00478-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-021-00478-3</ArticleId><ArticleId IdType="pmc">PMC8318062</ArticleId><ArticleId IdType="pubmed">34321065</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X., Liu Z., He X., Wang X., Yuan C., Huang L., et al. (2022). Risk of malnutrition in hospitalized COVID-19 patients: a systematic review and meta-analysis. Nutrients 14, 5267. 10.3390/nu14245267</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14245267</ArticleId><ArticleId IdType="pmc">PMC9780808</ArticleId><ArticleId IdType="pubmed">36558436</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Quintela A., Milton-Laskibar I., Trepiana J., G&#xf3;mez-Zorita S., Kajarabille N., L&#xe9;niz A., et al. (2020). Key aspects in nutritional management of COVID-19 patients. J. Clin. Med. 9, 2589. 10.3390/jcm9082589</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082589</ArticleId><ArticleId IdType="pmc">PMC7463687</ArticleId><ArticleId IdType="pubmed">32785121</ArticleId></ArticleIdList></Reference><Reference><Citation>
Franki R. (2020). Available at: https://www.the-hospitalist.org/hospitalist/article/220457/coronavirus-updates/comorbidities-rule-new-yorks-covid-19-deaths (Accessed December 27, 2022).</Citation></Reference><Reference><Citation>Frediansyah A., Nainu F., Dhama K., Mudatsir M., Harapan H. (2021). Remdesivir and its antiviral activity against COVID-19: a systematic review. Clin. Epidemiol. Glob. Health 9, 123&#x2013;127. 10.1016/j.cegh.2020.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2020.07.011</ArticleId><ArticleId IdType="pmc">PMC7410793</ArticleId><ArticleId IdType="pubmed">32838064</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A. K., Mishevich J. L., Mesecar A., Mitsuya H. (2022). Recent drug development and medicinal chemistry approaches for the treatment of SARS-CoV-2 infection and COVID-19. ChemMedChem 17, e202200440. 10.1002/cmdc.202200440</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.202200440</ArticleId><ArticleId IdType="pmc">PMC9538661</ArticleId><ArticleId IdType="pubmed">36165855</ArticleId></ArticleIdList></Reference><Reference><Citation>
Gisaid (2021). Gisaid. Available at: https://www.gisaid.org/hcov19-variants/ (Accessed January 4, 2023).</Citation></Reference><Reference><Citation>Greaney A. J., Starr T. N., Gilchuk P., Zost S. J., Binshtein E., Loes A. N., et al. (2021). Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29, 44&#x2013;57.e9. 10.1016/j.chom.2020.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.11.007</ArticleId><ArticleId IdType="pmc">PMC7676316</ArticleId><ArticleId IdType="pubmed">33259788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P., Gupta M., N K. A., Garg K., Garg B. (2021). A systematic review and meta-analysis of diabetes associated mortality in patients with COVID-19. Int. J. Endocrinol. Metab. 19, e113220. 10.5812/ijem.113220</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ijem.113220</ArticleId><ArticleId IdType="pmc">PMC8762284</ArticleId><ArticleId IdType="pubmed">35069750</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond J., Leister-Tebbe H., Gardner A., Abreu P., Bao W., Wisemandle W., et al. (2022). Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N. Engl. J. Med. 386, 1397&#x2013;1408. 10.1056/NEJMoa2118542</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey W. T., Carabelli A. M., Jackson B., Gupta R. K., Thomson E. C., Harrison E. M., et al. (2021). SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409&#x2013;424. 10.1038/s41579-021-00573-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemian S. M. R., Sheida A., Taghizadieh M., Memar M. Y., Hamblin M. R., Bannazadeh Baghi H., et al. (2023). Paxlovid (Nirmatrelvir/Ritonavir): a new approach to Covid-19 therapy? Biomed. Pharmacother. 162, 114367. 10.1016/j.biopha.2023.114367</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114367</ArticleId><ArticleId IdType="pmc">PMC9899776</ArticleId><ArticleId IdType="pubmed">37018987</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath L., Lim J. W. J., Taylor J. W., Saief T., Stuart R., Rimmer J., et al. (2021). Smell and taste loss in COVID-19 patients: assessment outcomes in a Victorian population. Acta Otolaryngol. 141, 299&#x2013;302. 10.1080/00016489.2020.1855366</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2020.1855366</ArticleId><ArticleId IdType="pubmed">33307905</ArticleId></ArticleIdList></Reference><Reference><Citation>Indo H. P., Yen H. C., Nakanishi I., Matsumoto K., Tamura M., Nagano Y., et al. (2015). A mitochondrial superoxide theory for oxidative stress diseases and aging. J. Clin. Biochem. Nutr. 56, 1&#x2013;7. 10.3164/jcbn.14-42</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.14-42</ArticleId><ArticleId IdType="pmc">PMC4306659</ArticleId><ArticleId IdType="pubmed">25834301</ArticleId></ArticleIdList></Reference><Reference><Citation>Intharuksa A., Arunotayanun W., Yooin W., Sirisa-Ard P. (2022). A comprehensive review of Andrographis paniculata (Burm. f.) Nees and its constituents as potential lead compounds for COVID-19 drug discovery. Molecules 27, 4479. 10.3390/molecules27144479</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27144479</ArticleId><ArticleId IdType="pmc">PMC9316804</ArticleId><ArticleId IdType="pubmed">35889352</ArticleId></ArticleIdList></Reference><Reference><Citation>Isidoro C., Chiung-Fang Chang A., Sheen L. Y. (2022). Natural products as a source of novel drugs for treating SARS-CoV2 infection. J. Tradit. Med. Complement. 12, 1&#x2013;5. 10.1016/j.jtcme.2022.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcme.2022.02.001</ArticleId><ArticleId IdType="pmc">PMC8822970</ArticleId><ArticleId IdType="pubmed">35155135</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam F., Bibi S., Meem A. F. K., Islam M. M., Rahaman M. S., Bepary S., et al. (2021). Natural bioactive molecules: an alternative approach to the treatment and control of COVID-19. Int. J. Mol. Sci. 22, 12638. 10.3390/ijms222312638</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222312638</ArticleId><ArticleId IdType="pmc">PMC8658031</ArticleId><ArticleId IdType="pubmed">34884440</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam T., Hasan M., Rahman M. S., Islam M. R. (2022). Comparative evaluation of authorized drugs for treating Covid-19 patients. Health Sci. Rep. 5, e671. 10.1002/hsr2.671</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.671</ArticleId><ArticleId IdType="pmc">PMC9194463</ArticleId><ArticleId IdType="pubmed">35734340</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. B., Farzan M., Chen B., Choe H. (2022). Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3&#x2013;20. 10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M., Sheng F., Zhang Z., Ma X., Gao T., Fu C., et al. (2021). Andrographis paniculata (Burm.f.) Nees and its major constituent andrographolide as potential antiviral agents. J. Ethnopharmacol. 272, 113954. 10.1016/j.jep.2021.113954</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.113954</ArticleId><ArticleId IdType="pubmed">33610706</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce R. P., Hu V. W., Wang J. (2022). The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations. Med. Chem. Res. 31, 1637&#x2013;1646. 10.1007/s00044-022-02951-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00044-022-02951-6</ArticleId><ArticleId IdType="pmc">PMC9425786</ArticleId><ArticleId IdType="pubmed">36060104</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim S. S. A., Karim Q. A. (2021). Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 398, 2126&#x2013;2128. 10.1016/s0140-6736(21)02758-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(21)02758-6</ArticleId><ArticleId IdType="pmc">PMC8640673</ArticleId><ArticleId IdType="pubmed">34871545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima A., Sekizawa A., Koide K., Hasegawa J., Satoh K., Arakaki T., et al. (2015). Vitamin C induces the reduction of oxidative stress and paradoxically stimulates the apoptotic gene expression in extravillous trophoblasts derived from first-trimester tissue. Reprod. Sci. 22, 783&#x2013;790. 10.1177/1933719114561561</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1933719114561561</ArticleId><ArticleId IdType="pmc">PMC4565473</ArticleId><ArticleId IdType="pubmed">25519716</ArticleId></ArticleIdList></Reference><Reference><Citation>Klouda C. B., Stone W. L. (2020). Oxidative stress, proton fluxes, and chloroquine/hydroxychloroquine treatment for COVID-19. Antioxidants 9, 894. 10.3390/antiox9090894</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9090894</ArticleId><ArticleId IdType="pmc">PMC7555760</ArticleId><ArticleId IdType="pubmed">32967165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L., Pennington A. F., Goodman A. B., Rosenblum H. G., Belay B., Ko J. Y., et al. (2021). Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Prev. Chronic Dis. 18, E66. 10.5888/pcd18.210123</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd18.210123</ArticleId><ArticleId IdType="pmc">PMC8269743</ArticleId><ArticleId IdType="pubmed">34197283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchta K., Cameron S., Lee M., Cai S. Q., Shoyama Y. (2022). Which East Asian herbal medicines can decrease viral infections? Phytochem. Rev. 21, 219&#x2013;237. 10.1007/s11101-021-09756-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11101-021-09756-2</ArticleId><ArticleId IdType="pmc">PMC8391007</ArticleId><ArticleId IdType="pubmed">34466134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz A., Grant K., Marano R., Arrieta A., Grant K., Feaster W., et al. (2021). Long-term effects of malnutrition on severity of COVID-19. Sci. Rep. 11, 14974. 10.1038/s41598-021-94138-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94138-z</ArticleId><ArticleId IdType="pmc">PMC8298504</ArticleId><ArticleId IdType="pubmed">34294743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb Y. N. (2022). Nirmatrelvir plus Ritonavir: first approval. Drugs 82, 585&#x2013;591. 10.1007/s40265-022-01692-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-022-01692-5</ArticleId><ArticleId IdType="pmc">PMC8933659</ArticleId><ArticleId IdType="pubmed">35305258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., et al. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215&#x2013;220. 10.1038/s41586-020-2180-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarevic I., Pravica V., Miljanovic D., Cupic M. (2021). Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far? Viruses 13, 1192. 10.3390/v13071192</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071192</ArticleId><ArticleId IdType="pmc">PMC8310325</ArticleId><ArticleId IdType="pubmed">34206453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565&#x2013;574. 10.1016/S0140-6736(20)30251-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Maares M., Haase H. (2016). Zinc and immunity: an essential interrelation. Arch. Biochem. Biophys. 611, 58&#x2013;65. 10.1016/j.abb.2016.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2016.03.022</ArticleId><ArticleId IdType="pubmed">27021581</ArticleId></ArticleIdList></Reference><Reference><Citation>Majima H. J., Indo H. P., Suenaga S., Matsui H., Yen H. C., Ozawa T. (2011). Mitochondria as possible pharmaceutical targets for the effects of vitamin E and its homologues in oxidative stress-related diseases. Curr. Pharm. Des. 17, 2190&#x2013;2195. 10.2174/138161211796957490</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161211796957490</ArticleId><ArticleId IdType="pubmed">21774784</ArticleId></ArticleIdList></Reference><Reference><Citation>Majima H. J., Oberley T. D., Furukawa K., Mattson M. P., Yen H. C., Szweda L. I., et al. (1998). Prevention of mitochondrial injury by manganese superoxide dismutase reveals a primary mechanism for alkaline-induced cell death. J. Biol. Chem. 273, 8217&#x2013;8224. 10.1074/jbc.273.14.8217</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.14.8217</ArticleId><ArticleId IdType="pubmed">9525927</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaronidis J., Firman C., Magee C. G., Mok J., Balogun N., Lechner M., et al. (2021). Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK. BMC Infect. Dis. 21, 221. 10.1186/s12879-021-05927-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05927-w</ArticleId><ArticleId IdType="pmc">PMC7905973</ArticleId><ArticleId IdType="pubmed">33632171</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekmohammad K., Rafieian-Kopaei M. (2021). Mechanistic aspects of medicinal plants and secondary metabolites against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Curr. Pharm. Des. 27, 3996&#x2013;4007. 10.2174/1381612827666210705160130</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612827666210705160130</ArticleId><ArticleId IdType="pubmed">34225607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo A., Bonato M., Cinque P. (2021). Smell and taste disorders in COVID-19: from pathogenesis to clinical features and outcomes. Neurosci. Lett. 748, 135694. 10.1016/j.neulet.2021.135694</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2021.135694</ArticleId><ArticleId IdType="pmc">PMC7883672</ArticleId><ArticleId IdType="pubmed">33600902</ArticleId></ArticleIdList></Reference><Reference><Citation>Min L., Sun Q. (2021). Antibodies and vaccines target RBD of SARS-CoV-2. Front. Mol. Biosci. 8, 671633. 10.3389/fmolb.2021.671633</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.671633</ArticleId><ArticleId IdType="pmc">PMC8100443</ArticleId><ArticleId IdType="pubmed">33968996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mironova G. D., Belosludtseva N. V., Ananyan M. A. (2020). Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications. Eur. Rev. Med. Pharmacol. Sci. 24, 8585&#x2013;8591. 10.26355/eurrev_202008_22658</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202008_22658</ArticleId><ArticleId IdType="pubmed">32894566</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosquera-Yuqui F., Lopez-Guerra N., Moncayo-Palacio E. A. (2022). Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations. J. Biomol. Struct. Dyn. 40, 2010&#x2013;2023. 10.1080/07391102.2020.1835716</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1835716</ArticleId><ArticleId IdType="pmc">PMC7657401</ArticleId><ArticleId IdType="pubmed">33084512</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee P. K., Efferth T., Das B., Kar A., Ghosh S., Singha S., et al. (2022). Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications. Phytomedicine 98, 153930. 10.1016/j.phymed.2022.153930</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2022.153930</ArticleId><ArticleId IdType="pmc">PMC8730822</ArticleId><ArticleId IdType="pubmed">35114450</ArticleId></ArticleIdList></Reference><Reference><Citation>
Multum C. (2024). Nirmatrelvir and ritonavir. Nirmatrelvir and ritonavir side effects. Drugs Com.
Available at: https://www.drugs.com/mtm/nirmatrelvir-and-ritonavir.html (Accessed December 15, 2023).
</Citation></Reference><Reference><Citation>Nabeshima A., Sakamoto A., Iwata K., Kitamura Y., Masui S., Inomata S., et al. (2022). Maoto, a traditional herbal medicine, for post-exposure prophylaxis for Japanese healthcare workers exposed to COVID-19: a single center study. J. Infect. Chemother. 28, 907&#x2013;911. 10.1016/j.jiac.2022.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.03.014</ArticleId><ArticleId IdType="pmc">PMC8934734</ArticleId><ArticleId IdType="pubmed">35361537</ArticleId></ArticleIdList></Reference><Reference><Citation>
Nguyen P. A., Prouty E. (2023). Available at: https://www.verywellhealth.com/lagevrio-molnupiravir-vs-paxlovid-nirmatrelvir-ritonavir-7496436 (Accessed August 1, 2024).</Citation></Reference><Reference><Citation>Nicholson B. L., White K. A. (2014). Functional long-range RNA&#x2013;RNA interactions in positive-strand RNA viruses. Nat. Rev. Microbiol. 12, 493&#x2013;504. 10.1038/nrmicro3288</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3288</ArticleId><ArticleId IdType="pmc">PMC7097572</ArticleId><ArticleId IdType="pubmed">24931042</ArticleId></ArticleIdList></Reference><Reference><Citation>
Nih (2024). Available at: https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/ritonavir-boosted-nirmatrelvir--paxlovid-/ (Accessed April 12, 2024).</Citation></Reference><Reference><Citation>Noonong K., Chatatikun M., Surinkaew S., Kotepui M., Hossain R., Bunluepuech K., et al. (2023). Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis. Front. Immunol. 14, 1275001. 10.3389/fimmu.2023.1275001</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1275001</ArticleId><ArticleId IdType="pmc">PMC10766822</ArticleId><ArticleId IdType="pubmed">38187378</ArticleId></ArticleIdList></Reference><Reference><Citation>Noori M., Nejadghaderi S. A., Arshi S., Carson-Chahhoud K., Ansarin K., Kolahi A.-A., et al. (2022). Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: a systematic review of in vitro studies. Rev. Med. Virol. 32, e2277. 10.1002/rmv.2277</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2277</ArticleId><ArticleId IdType="pmc">PMC8420542</ArticleId><ArticleId IdType="pubmed">34286893</ArticleId></ArticleIdList></Reference><Reference><Citation>Parente-Arias P., Barreira-Fernandez P., Quintana-Sanjuas A., Pati&#xf1;o-Casti&#xf1;eira B. (2021). Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019. Am. J. Otolaryngol. 42, 102648. 10.1016/j.amjoto.2020.102648</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102648</ArticleId><ArticleId IdType="pmc">PMC7358151</ArticleId><ArticleId IdType="pubmed">33799139</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H. L., Lee H. S., Shin B. C., Liu J. P., Shang Q., Yamashita H., et al. (2012). Traditional medicine in China, Korea, and Japan: a brief introduction and comparison. Evid. Based Complement. Altern. Med. 2012, 429103. 10.1155/2012/429103</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/429103</ArticleId><ArticleId IdType="pmc">PMC3486438</ArticleId><ArticleId IdType="pubmed">23133492</ArticleId></ArticleIdList></Reference><Reference><Citation>Paudel S. S. (2020). Preprint from research square. Available at: 10.21203/rs.3.rs-21831/v1 [Accessed 10 December 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-21831/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillaiyar T., Manickam M., Namasivayam V., Hayashi Y., Jung S.-H. (2016). An overview of severe acute respiratory syndrome&#x2013;coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J. Med. Chem. 59, 6595&#x2013;6628. 10.1021/acs.jmedchem.5b01461</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b01461</ArticleId><ArticleId IdType="pmc">PMC7075650</ArticleId><ArticleId IdType="pubmed">26878082</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasansuklab A., Theerasri A., Rangsinth P., Sillapachaiyaporn C., Chuchawankul S., Tencomnao T. (2021). Anti-COVID-19 drug candidates: a review on potential biological activities of natural products in the management of new coronavirus infection. J. Tradit. Med. Complement. 11, 144&#x2013;157. 10.1016/j.jtcme.2020.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcme.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7833040</ArticleId><ArticleId IdType="pubmed">33520683</ArticleId></ArticleIdList></Reference><Reference><Citation>Printza A., Katotomichelakis M., Valsamidis K., Metallidis S., Panagopoulos P., Panopoulou M., et al. (2021). Smell and taste loss recovery time in COVID-19 patients and disease severity. J. Clin. Med. 10, 966. 10.3390/jcm10050966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10050966</ArticleId><ArticleId IdType="pmc">PMC7957474</ArticleId><ArticleId IdType="pubmed">33801170</ArticleId></ArticleIdList></Reference><Reference><Citation>Prodromos C., Rumschlag T. (2020). Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review. New Microbes New Infect. 38, 100776. 10.1016/j.nmni.2020.100776</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100776</ArticleId><ArticleId IdType="pmc">PMC7534595</ArticleId><ArticleId IdType="pubmed">33042552</ArticleId></ArticleIdList></Reference><Reference><Citation>Puckey M. (2024). Paxlovid. Drugs.Com.</Citation></Reference><Reference><Citation>Sanyaolu A., Okorie C., Marinkovic A., Patidar R., Younis K., Desai P., et al. (2020). Comorbidity and its impact on patients with COVID-19. SN Compr. Clin. Med. 2, 1069&#x2013;1076. 10.1007/s42399-020-00363-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00363-4</ArticleId><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson R. J., Campbell J. P., Gleeson M., Kr&#xfc;ger K., Nieman D. C., Pyne D. B., et al. (2020). Can exercise affect immune function to increase susceptibility to infection? Exerc. Immunol. Rev. 26, 8&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32139352</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A. K., Singh A., Singh R., Misra A. (2022). An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19. Diabetes Metab. Syndr. Clin. Res. and Rev. 16, 102396. 10.1016/j.dsx.2022.102396</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2022.102396</ArticleId><ArticleId IdType="pmc">PMC8755553</ArticleId><ArticleId IdType="pubmed">35051686</ArticleId></ArticleIdList></Reference><Reference><Citation>Singla R. K., He X., Chopra H., Tsagkaris C., Shen L., Kamal M. A., et al. (2021). Natural products for the prevention and control of the COVID-19 pandemic: sustainable bioresources. Front. Pharmacol. 12, 758159. 10.3389/fphar.2021.758159</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.758159</ArticleId><ArticleId IdType="pmc">PMC8671886</ArticleId><ArticleId IdType="pubmed">34925017</ArticleId></ArticleIdList></Reference><Reference><Citation>Soleymani S., Naghizadeh A., Karimi M., Zarei A., Mardi R., Kordafshari G., et al. (2022). COVID-19: general strategies for herbal therapies. J. Evid.-Based Integr. Med. 27, 2515690x211053641. 10.1177/2515690x211053641</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2515690x211053641</ArticleId><ArticleId IdType="pmc">PMC8744081</ArticleId><ArticleId IdType="pubmed">34985368</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza P. F. N., Mesquita F. P., Amaral J. L., Landim P. G. C., Lima K. R. P., Costa M. B., et al. (2022). The spike glycoprotein of SARS-CoV-2: a review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape. Int. J. Biol. Macromol. 208, 105&#x2013;125. 10.1016/j.ijbiomac.2022.03.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2022.03.058</ArticleId><ArticleId IdType="pmc">PMC8920968</ArticleId><ArticleId IdType="pubmed">35300999</ArticleId></ArticleIdList></Reference><Reference><Citation>Strizki J. M., Grobler J. A., Murgolo N., Fridman A., Johnson M. G., Du J., et al. (2023). Virologic outcomes with molnupiravir in non-hospitalized adult patients with COVID-19 from the randomized, placebo-controlled move-out trial. Infect. Dis. Ther. 12, 2725&#x2013;2743. 10.1007/s40121-023-00891-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-023-00891-1</ArticleId><ArticleId IdType="pmc">PMC10746688</ArticleId><ArticleId IdType="pubmed">37995070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir Ul Qamar M., Alqahtani S. M., Alamri M. A., Chen L. L. (2020). Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 10, 313&#x2013;319. 10.1016/j.jpha.2020.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2020.03.009</ArticleId><ArticleId IdType="pmc">PMC7156227</ArticleId><ArticleId IdType="pubmed">32296570</ArticleId></ArticleIdList></Reference><Reference><Citation>Takayama S., Namiki T., Odaguchi H., Arita R., Hisanaga A., Mitani K., et al. (2021). Prevention and recovery of COVID-19 patients with Kampo medicine: review of case reports and ongoing clinical trials. Front. Pharmacol. 12, 656246. 10.3389/fphar.2021.656246</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.656246</ArticleId><ArticleId IdType="pmc">PMC8261067</ArticleId><ArticleId IdType="pubmed">34248620</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Meij B. S., Ligthart-Melis G. C., De Van Der Schueren M. a.E. (2021). Malnutrition in patients with COVID-19: assessment and consequences. Curr. Opin. Clin. Nutr. Metab. Care 24, 543&#x2013;554. 10.1097/mco.0000000000000783</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mco.0000000000000783</ArticleId><ArticleId IdType="pubmed">34419971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen C.-C., Kuo Y.-H., Jan J.-T., Liang P.-H., Wang S.-Y., Liu H.-G., et al. (2007). Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 50, 4087&#x2013;4095. 10.1021/jm070295s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm070295s</ArticleId><ArticleId IdType="pubmed">17663539</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO (2023). WHO. Available at: https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-%28covid-19%29 (Accessed December 28, 2023).</Citation></Reference><Reference><Citation>Wu W., Cheng Y., Zhou H., Sun C., Zhang S. (2023). The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virol. J. 20, 6. 10.1186/s12985-023-01968-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-01968-6</ArticleId><ArticleId IdType="pmc">PMC9831023</ArticleId><ArticleId IdType="pubmed">36627683</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72&#x202f;314 cases from the Chinese Center for Disease Control and Prevention. JAMA 7, 1239&#x2013;1242. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian Y., Zhang J., Bian Z., Zhou H., Zhang Z., Lin Z., et al. (2020). Bioactive natural compounds against human coronaviruses: a review and perspective. Acta Pharm. Sin. B 10, 1163&#x2013;1174. 10.1016/j.apsb.2020.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC7278644</ArticleId><ArticleId IdType="pubmed">32834947</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan D., Yan B. (2023). Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: molnupiravir, nirmatrelvir, and remdesivir. Fundam. Clin. Pharmacol. 37, 726&#x2013;738. 10.1111/fcp.12889</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/fcp.12889</ArticleId><ArticleId IdType="pmc">PMC10505250</ArticleId><ArticleId IdType="pubmed">36931725</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Islam M. S., Wang J., Li Y., Chen X. (2020). Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int. J. Biol. Sci. 16, 1708&#x2013;1717. 10.7150/ijbs.45538</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.45538</ArticleId><ArticleId IdType="pmc">PMC7098036</ArticleId><ArticleId IdType="pubmed">32226288</ArticleId></ArticleIdList></Reference><Reference><Citation>
Yap F. (2023). Available at: https://covid19.onedaymd.com/2022/10/paxlovid-vs-remdesivir-vs-monoclonal.html (Accessed July 30, 2024).</Citation></Reference><Reference><Citation>Zhou S., Hill C. S., Sarkar S., Tse L. V., Woodburn B. M. D., Schinazi R. F., et al. (2021). &#x3b2;-d-N4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells. J. Infect. Dis. 224, 415&#x2013;419. 10.1093/infdis/jiab247</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab247</ArticleId><ArticleId IdType="pmc">PMC8136050</ArticleId><ArticleId IdType="pubmed">33961695</ArticleId></ArticleIdList></Reference><Reference><Citation>Zibat A., Zhang X., Dickmanns A., Stegmann K. M., Dobbelstein A. W., Alachram H., et al. (2023). N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody. iScience 26, 107786. 10.1016/j.isci.2023.107786</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107786</ArticleId><ArticleId IdType="pmc">PMC10507161</ArticleId><ArticleId IdType="pubmed">37731621</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>